Stephanie E. Areloegbe

发表

Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model

K. Olaniyi, I. W. Sabinari, Abdul Bashir, 2022, PloS one.

Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model

K. Olaniyi, M. B. Oyeleke, Stephanie E. Areloegbe, 2022, BMC Endocrine Disorders.

Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome.

K. Olaniyi, Stephanie E. Areloegbe, 2022, Life sciences.

Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model

K. Olaniyi, C. Akintayo, Adesola A. Oniyide, 2022, Journal of Diabetes & Metabolic Disorders.

Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation

K. Olaniyi, Stephanie E. Areloegbe, John A Wolugbom, 2022, Molecular neurobiology.

Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity

K. Olaniyi, M. B. Oyeleke, Stephanie E. Areloegbe, 2022, Endocrine.

Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats

K. Olaniyi, Stephanie E. Areloegbe, A. Oyabambi, 2023, Nutrire.

Modulatory effect of PPAR-γ by acetate on cardiorenometabolic disturbance associated with high fat diet–fed insulin-resistant male Wistar rats

K. Olaniyi, Isaac O. Ajadi, Stephanie E. Areloegbe, 2023, Comparative Clinical Pathology.

Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome

K. Olaniyi, Stephanie E. Areloegbe, 2022, The Journal of Steroid Biochemistry and Molecular Biology.

Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome.

K. Olaniyi, E. Areola, L. Olatunji, 2023, Toxicology and applied pharmacology.

Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model

K. Olaniyi, C. Akintayo, Adesola A. Oniyide, 2022, Journal of Diabetes & Metabolic Disorders.

Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats

K. Olaniyi, Stephanie E. Areloegbe, A. Oyabambi, 2023, Nutrire.

Panax ginseng supplementation protects against testicular damage induced by radiofrequency electromagnetic radiation from cell phone

K. Olaniyi, Isaac O. Ajadi, Ayodeji Aturamu, 2023, Nutrire.

Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR.

K. Olaniyi, Stephanie E. Areloegbe, Kehinde S. Olaniyi, 2023, European journal of pharmacology.

Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3.

K. Olaniyi, Stephanie E. Areloegbe, 2022, Nutrition (Burbank, Los Angeles County, Calif.).

Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism

Stephanie E. Areloegbe, Kehinde S. Olaniyi, 2024, Nutrire.